Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.

Cancers (Basel) · 2023 · PMC10648983 · PMID 37958421

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Among the variables analyzed, the type of anticancer drug used, categorized as C, CI, I, or M, emerged as a highly significant factor affecting 5-year OS.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.